![Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns | Experimental Hematology & Oncology | Full Text Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns | Experimental Hematology & Oncology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs40164-021-00207-4/MediaObjects/40164_2021_207_Fig2_HTML.png)
Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns | Experimental Hematology & Oncology | Full Text
![Gene mutation profile and risk stratification in AML1‑ETO‑positive acute myeloid leukemia based on next‑generation sequencing Gene mutation profile and risk stratification in AML1‑ETO‑positive acute myeloid leukemia based on next‑generation sequencing](https://www.spandidos-publications.com/article_images/or/42/6/or-42-06-2333-g00.jpg)
Gene mutation profile and risk stratification in AML1‑ETO‑positive acute myeloid leukemia based on next‑generation sequencing
![Unraveling novel genes that are essential for acute myeloid leukemia and normal hematopoiesis | Semantic Scholar Unraveling novel genes that are essential for acute myeloid leukemia and normal hematopoiesis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5613af4b01fd968b6f0c1448f1ea3746c2494daf/22-Figure3-1.png)
Unraveling novel genes that are essential for acute myeloid leukemia and normal hematopoiesis | Semantic Scholar
![IJMS | Free Full-Text | Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia IJMS | Free Full-Text | Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia](https://www.mdpi.com/ijms/ijms-23-04694/article_deploy/html/images/ijms-23-04694-g003.png)
IJMS | Free Full-Text | Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia
![Oncogenic KIT mutations induce STAT3-dependent autophagy to support cell proliferation in acute myeloid leukemia | Oncogenesis Oncogenic KIT mutations induce STAT3-dependent autophagy to support cell proliferation in acute myeloid leukemia | Oncogenesis](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41389-019-0148-9/MediaObjects/41389_2019_148_Fig1_HTML.png)
Oncogenic KIT mutations induce STAT3-dependent autophagy to support cell proliferation in acute myeloid leukemia | Oncogenesis
High Expression of c-kit mRNA Predicts Unfavorable Outcome in Adult Patients with t(8;21) Acute Myeloid Leukemia | PLOS ONE
![PDF] Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia | Semantic Scholar PDF] Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/608cfe9e4c6abfd22f6b2e759828e3a21b729a43/4-Figure1-1.png)
PDF] Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia | Semantic Scholar
![The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia | Blood Cancer Journal The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-021-00461-z/MediaObjects/41408_2021_461_Fig2_HTML.png)
The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia | Blood Cancer Journal
![KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis | Leukemia KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-018-0346-z/MediaObjects/41375_2018_346_Fig4_HTML.png)
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis | Leukemia
![IJMS | Free Full-Text | Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia IJMS | Free Full-Text | Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia](https://www.mdpi.com/ijms/ijms-23-04694/article_deploy/html/images/ijms-23-04694-g002.png)
IJMS | Free Full-Text | Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia
![Current findings for recurring mutations in acute myeloid leukemia | Journal of Hematology & Oncology | Full Text Current findings for recurring mutations in acute myeloid leukemia | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2F1756-8722-4-36/MediaObjects/13045_2011_Article_170_Fig1_HTML.jpg)
Current findings for recurring mutations in acute myeloid leukemia | Journal of Hematology & Oncology | Full Text
![Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the 'second hit' hypothesis | Leukemia Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the 'second hit' hypothesis | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2008.61/MediaObjects/41375_2008_Article_BFleu200861_Fig1_HTML.jpg)
Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the 'second hit' hypothesis | Leukemia
![KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis | Leukemia KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-018-0346-z/MediaObjects/41375_2018_346_Fig1_HTML.png)
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis | Leukemia
![Prognostic impact of KIT exon 17 mutations by allele-specific real-time... | Download Scientific Diagram Prognostic impact of KIT exon 17 mutations by allele-specific real-time... | Download Scientific Diagram](https://www.researchgate.net/publication/290598131/figure/fig3/AS:318528499535876@1452954520559/Prognostic-impact-of-KIT-exon-17-mutations-by-allele-specific-real-time-PCR-in-CBF-AML.png)